DESCRIPTION OF DRAWINGS
The application of the preferred embodiments of the present invention is best understood with reference to the accompanying drawings, wherein:
FIG. 1-FIG. 3 are photographs illustrating that the pathological findings about lung tissues of neonatal rats induced with bronchopulmonary dysplasia, one of the developmental and/or chronic lung diseases, after treating with the method of the invention. FIG. 1 represents the normal control (NC), FIG. 2 represents the hyperoxia-exposed group (HC), and FIG. 3 represents the hyperoxia-exposed and umbilical cord blood mesenchymal stem cell transplanting group (HT).
FIG. 4 is a graph illustrating the alveolar development in the lung of a neonatal rat induced with bronchopulmonary dysplasia, one of the developmental and/or chronic lung disease, after treating with the method of the invention,
NC: normal control
HC: hyperoxia-exposed group (bronchopulmonary dysplasia)
HT: hyperoxia-exposed and umbilical cord blood mesenchymal stem cell transplanting group
*significant difference with NC group (p<0.05)
#significant difference with HC group (p<0.05)
FIG. 5 is a photograph illustrating that the therapeutic cell component was safely located by the method of the invention in the lung of a neonatal rat induced with bronchopulmonary dysplasia,
Blue: nuclei stained with DAPI,
Red: labeled with PKH26
Patent Application
20070178073
